Ryan D. Cassaday, MD; Aaron C. Logan, MD, PhD; Anthony S. Stein, MD; Mark R. Litzow, MD; and Bijal D. Shah, MD, share their personal approaches and preferential regimens for treating a patient who is MRD-positive after induction therapy for acute lymphoblastic leukemia.